Potentiometric and calorimetric studies on the formation of ethylenediamine complexes of copper(II) ion in water and aqueous dioxane solutions.
スポンサーリンク
概要
- 論文の詳細を見る
Gibbs energies (or formation constants), enthalpies and entropies of formation of ethylenediamine complexes of copper(II) ions have been determined by means of potentiometric and calorimetric titrations at 25 °C in an aqueous solution and dioxane–water mixtures (dioxane contents are 0.1 and 0.2 mole fractions, which correspond to 35.2 and 55.0% w/w, respectively), all containing 3 mol dm<SUP>−3</SUP> LiClO<SUB>4</SUB> as a constant ionic medium. The thermodynamic quantities of the reactions CuL<SUB><I>n</I>−1</SUB><SUP>2+</SUP>+L=CuL<I><SUB>n</SUB></I><SUP>2+</SUP> (L=ethylenediamine and <I>n</I>=1 and 2) determined in the solutions were as follows: Δ<I>G</I><SUB>1</SUB><SUP>°</SUP>=−65.0 kJ mol<SUP>−1</SUP> (dioxane content: 0.0 mole fraction), −66.8 kJ mol<SUP>−1</SUP> (0.1 mole fraction), and −68.8 kJ mol<SUP>−1</SUP> (0.2 mole fraction); Δ<I>G</I><SUB>2</SUB><SUP>°</SUP>=−56.9 kJ mol<SUP>−1</SUP> (0.0), −58.8 kJ mol<SUP>−1</SUP> (0.1), and −61.1 kJ mol<SUP>−1</SUP> (0.2); Δ<I>H</I><SUB>1</SUB><SUP>°</SUP>=−67.7 kJ mol<SUP>−1</SUP> (0.0), −68.6 kJ mol<SUP>−1</SUP> (0.1), and −66.7 kJ mol<SUP>−1</SUP> (0.2); Δ<I>H</I><SUB>2</SUB><SUP>°</SUP>=−71.0 kJ mol<SUP>−1</SUP> (0.0), −70.2 kJ mol<SUP>−1</SUP> (0.1), and −68.8 kJ mol<SUP>−1</SUP> (0.2); <I>T</I>Δ<I>S</I><SUB>1</SUB><SUP>°</SUP>=−2.7 kJ mol<SUP>−1</SUP> (0.0), −1.8 kJ mol<SUP>−1</SUP>(0.1), and 2.1 kJ mol<SUP>−1</SUP> (0.2); <I>T</I>Δ<I>S</I><SUB>2</SUB><SUP>°</SUP>=−14.1 kJ mol<SUP>−1</SUP> (0.0), −11.4 kJ mol<SUP>−1</SUP>(0.1), and −7.7 kJ mol<SUP>−1</SUP> (0.2). In any solvent examined the enthalpies contribute predominantly to the Gibbs energies. On the other hand, for a given complex with varying solvent compositions, the entropies mainly contribute to the change in the Gibbs energies of the complex formation reactions. With an increase in the dioxane content of the solvent, the Gibbs energies of the complex formation reactions become more negative, while the enthalpies of the reactions remain practically unchanged or even become less negative. Consequently, the entropies of the reactions increase with increasing dioxane content of the solvent, which is explained in terms of weakening of the hydrogen-bonded structure of water in the bulk solvent by the addition of dioxane.
- 公益社団法人 日本化学会の論文
著者
-
Ohtaki Hitoshi
Department Of Chemistry Faculty Of Science And Engineering Ritsumeikan University
-
Ishiguro Shin-ichi
Department Of Chemistry Faculty Of Science Kyushu University
-
Oka Yoshihiro
Department of Electronic Chemistry, Tokyo Institute of Technology at Nagatsuta
関連論文
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
- Unmanipulated Reduced-Intensity Stem Cell Transplantation from a Haploidentical Donor Mismatched at 3 HLA Antigens to a Patient with Leukemic Transformation of Myelodysplastic Syndrome : Successful Second Transplantation after Graft Rejection
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies